• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型系统性假性醛固酮减少症:病例报告及文献综述

Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.

作者信息

Nur Nasifa, Lang Cameron, Hodax Juanita K, Quintos Jose Bernardo

机构信息

Division of Pediatric Endocrinology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, RI, USA.

Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

出版信息

Case Rep Pediatr. 2017;2017:7939854. doi: 10.1155/2017/7939854. Epub 2017 Apr 18.

DOI:10.1155/2017/7939854
PMID:28484659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5412170/
Abstract

Systemic pseudohypoaldosteronism (PHA) type I is a rare genetic disorder resulting from mutations in the subunits of the epithelial sodium channel that manifests as severe salt wasting, hyperkalemia, and metabolic acidosis in infancy. In this article we report a patient with systemic PHA type I presenting with severe dehydration due to salt wasting at 6 days of life. She was found to have a known mutation in the SCNN1A gene and subsequently required treatment with sodium supplementation. We also review the clinical presentation, differential diagnosis, and treatment of systemic PHA type I and summarize data from 27 cases with follow-up data.

摘要

I型系统性假性醛固酮增多症(PHA)是一种罕见的遗传性疾病,由上皮钠通道亚基突变引起,在婴儿期表现为严重的盐消耗、高钾血症和代谢性酸中毒。在本文中,我们报告了一名I型系统性PHA患者,该患者在出生6天时因盐消耗出现严重脱水。她被发现SCNN1A基因存在已知突变,随后需要补充钠进行治疗。我们还回顾了I型系统性PHA的临床表现、鉴别诊断和治疗,并总结了27例有随访数据的病例资料。

相似文献

1
Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.I型系统性假性醛固酮减少症:病例报告及文献综述
Case Rep Pediatr. 2017;2017:7939854. doi: 10.1155/2017/7939854. Epub 2017 Apr 18.
2
Case report: Early molecular confirmation and sodium polystyrene sulfonate management of systemic pseudohypoaldosteronism type I.病例报告:I 型全身性假性醛固酮减少症的早期分子确认和聚苯乙烯磺酸钠管理。
Front Endocrinol (Lausanne). 2024 Jan 15;14:1297335. doi: 10.3389/fendo.2023.1297335. eCollection 2023.
3
Clinical Management in Systemic Type Pseudohypoaldosteronism Due to Variant and Literature Review.系统型假性醛固酮减少症伴变异型的临床处理及文献复习。
J Clin Res Pediatr Endocrinol. 2021 Nov 25;13(4):446-451. doi: 10.4274/jcrpe.galenos.2020.2020.0107. Epub 2020 Aug 25.
4
Systemic Pseudohypoaldosteronism Type 1 Due to a Novel Mutation in SCNN1B Gene: A Case Report.因SCNN1B基因新突变导致的1型全身性假性醛固酮减少症:一例报告
EJIFCC. 2022 Oct 28;33(3):268-273. eCollection 2022 Oct.
5
A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1.一例因SCNN1A剪接突变导致的轻度1型全身性假性醛固酮减少症病例。
J Pediatr Endocrinol Metab. 2013;26(11-12):1197-200. doi: 10.1515/jpem-2013-0053.
6
Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B.伊朗一男孩患 PHA1B,其 SCNN1A 基因中存在新型纯合突变。
J Pediatr Endocrinol Metab. 2024 Jul 5;37(8):745-749. doi: 10.1515/jpem-2023-0505. Print 2024 Aug 27.
7
Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.1型假性醛固酮减少症的表型多样性及其与基因型的相关性。
J Pediatr Endocrinol Metab. 2019 Sep 25;32(9):959-967. doi: 10.1515/jpem-2018-0538.
8
Pseudohypoaldosteronism type 1: clinical features and management in infancy.1型假性醛固酮减少症:婴儿期的临床特征与管理
Endocrinol Diabetes Metab Case Rep. 2013;2013:130010. doi: 10.1530/EDM-13-0010. Epub 2013 Aug 30.
9
Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.系统性假性醛固酮减少症 1 型:3 个 SCNN1A 和 SCNN1B 基因突变所致。
Horm Res Paediatr. 2019;91(3):175-185. doi: 10.1159/000498860. Epub 2019 Apr 24.
10
Pseudohypoaldosteronism type-I: a rare cause of hyperkalemia in neonates.I型假性醛固酮减少症:新生儿高钾血症的罕见病因。
J Pak Med Assoc. 2014 Apr;64(4):484-6.

引用本文的文献

1
Case Report: Autoimmune hepatitis in a patient with pseudohypoaldosteronism type 1-insights into a rare co-occurrence.病例报告:1型假性醛固酮减少症患者合并自身免疫性肝炎——对一种罕见共病情况的深入了解
Front Pediatr. 2025 Apr 15;13:1558179. doi: 10.3389/fped.2025.1558179. eCollection 2025.
2
Pseudohypoaldosteronism Type 1B and Cohen Syndrome: Novel Mutation, Unusual Combination, and Presentation.1B型假性醛固酮减少症与科恩综合征:新突变、罕见组合及临床表现
Cureus. 2024 Mar 29;16(3):e57217. doi: 10.7759/cureus.57217. eCollection 2024 Mar.
3
Cardiac arrest in a newborn: A case of pseudohypoaldosteronism.新生儿心脏骤停:一例假性醛固酮减少症病例。
Clin Case Rep. 2024 Feb 9;12(2):e8265. doi: 10.1002/ccr3.8265. eCollection 2024 Feb.
4
Case report: Early molecular confirmation and sodium polystyrene sulfonate management of systemic pseudohypoaldosteronism type I.病例报告:I 型全身性假性醛固酮减少症的早期分子确认和聚苯乙烯磺酸钠管理。
Front Endocrinol (Lausanne). 2024 Jan 15;14:1297335. doi: 10.3389/fendo.2023.1297335. eCollection 2023.
5
Case Report: A Novel Compound Heterozygote Mutation of the Gene Identified in a Chinese Familial Pseudohypoaldosteronism Disease Type I With Persistent Hyperkalemia.病例报告:在中国一例伴有持续性高钾血症的I型家族性假性醛固酮增多症疾病中鉴定出该基因的一种新型复合杂合子突变。
Front Pediatr. 2022 Mar 10;10:831284. doi: 10.3389/fped.2022.831284. eCollection 2022.
6
Diagnostic and management considerations in pseudohypoaldosteronism type 1b.1b 型假性醛固酮增多症的诊断和治疗注意事项。
BMJ Case Rep. 2022 Jan 3;15(1):e246538. doi: 10.1136/bcr-2021-246538.
7
A Novel Variation in a Patient with Autosomal-recessive Pseudohypoaldosteronism Type 1.一例常染色体隐性遗传假性醛固酮减少症 1 型患者的新变异。
J Clin Res Pediatr Endocrinol. 2022 Jun 7;14(2):244-250. doi: 10.4274/jcrpe.galenos.2021.2020.0175. Epub 2021 Apr 8.
8
Clinical Management in Systemic Type Pseudohypoaldosteronism Due to Variant and Literature Review.系统型假性醛固酮减少症伴变异型的临床处理及文献复习。
J Clin Res Pediatr Endocrinol. 2021 Nov 25;13(4):446-451. doi: 10.4274/jcrpe.galenos.2020.2020.0107. Epub 2020 Aug 25.
9
An infantile case of pseudohypoaldosteronism type 1 (PHA1) caused by a novel mutation of .一例由……的新型突变引起的1型假性醛固酮减少症(PHA1)婴儿病例。 (原文此处“of”后内容缺失)
Clin Pediatr Endocrinol. 2020;29(3):127-130. doi: 10.1297/cpe.29.127. Epub 2020 Jul 11.
10
Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies.囊性纤维化:当前发展趋势与创新治疗策略概述
Pharmaceutics. 2020 Jul 2;12(7):616. doi: 10.3390/pharmaceutics12070616.

本文引用的文献

1
Expression of epithelial sodium channel (ENaC) and CFTR in the human epidermis and epidermal appendages.上皮钠通道(ENaC)和囊性纤维化跨膜传导调节因子(CFTR)在人表皮及表皮附属器中的表达。
Histochem Cell Biol. 2017 Jun;147(6):733-748. doi: 10.1007/s00418-016-1535-3. Epub 2017 Jan 27.
2
Epithelial sodium channel (ENaC) family: Phylogeny, structure-function, tissue distribution, and associated inherited diseases.上皮钠通道(ENaC)家族:系统发育、结构功能、组织分布及相关遗传性疾病
Gene. 2016 Apr 1;579(2):95-132. doi: 10.1016/j.gene.2015.12.061. Epub 2016 Jan 7.
3
A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1.一例因SCNN1A剪接突变导致的轻度1型全身性假性醛固酮减少症病例。
J Pediatr Endocrinol Metab. 2013;26(11-12):1197-200. doi: 10.1515/jpem-2013-0053.
4
A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.一名患有全身性1型假性醛固酮减少症的土耳其患者上皮钠通道(ENaC)β亚基基因的一种新型剪接位点突变。
J Pediatr Endocrinol Metab. 2012;25(9-10):1035-9. doi: 10.1515/jpem-2012-0083.
5
Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1.五个导致常染色体隐性假性醛固酮增多症 1 型的 SCNN1A 基因突变。
Eur J Endocrinol. 2013 Apr 15;168(5):707-15. doi: 10.1530/EJE-12-1000. Print 2013 May.
6
Critical points in the management of pseudohypoaldosteronism type 1.1型假性醛固酮减少症管理中的关键点
J Clin Res Pediatr Endocrinol. 2011;3(2):98-100. doi: 10.4274/jcrpe.v3i2.20. Epub 2011 Jun 8.
7
Aldosterone resistance: structural and functional considerations and new perspectives.醛固酮抵抗:结构和功能的考虑因素及新视角。
Mol Cell Endocrinol. 2012 Mar 24;350(2):206-15. doi: 10.1016/j.mce.2011.04.023. Epub 2011 Jun 1.
8
A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.SCNN1A 中的纯合错义突变导致暂时性新生儿型 1 型假性醛固酮减少症。
Am J Physiol Endocrinol Metab. 2011 Sep;301(3):E467-73. doi: 10.1152/ajpendo.00066.2011. Epub 2011 Jun 7.
9
Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism.常染色体隐性遗传假性醛固酮减少症中通过钠-氯共转运蛋白增加钠重吸收。
Clin Exp Nephrol. 2010 Jun;14(3):228-32. doi: 10.1007/s10157-010-0277-0. Epub 2010 Apr 8.
10
Transient Pseudohypoaldosteronism due to Urinary Tract Infection in Infancy: A Report of 4 Cases.婴儿期尿路感染所致短暂性假性醛固酮减少症:4例报告
Int J Pediatr Endocrinol. 2009;2009:195728. doi: 10.1155/2009/195728. Epub 2009 May 21.